Schedule 13D ownership disclosure
LIPELLA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 53630L100
Event date: 2023-06-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,268,443
- Percent of class
- 20.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-23-000837
- Form type
- SC 13D
- Filer
- Kaufman Jonathan H
- CIK
- CIK 1959250
- Filed
- Jun 21, 2023
- Reporting period
- Jun 16, 2023
- Description
- Schedule 13D beneficial ownership